OmniActive Health Technologies Acquires ENovate Biolife to Expand Portfolio of Clinically Proven Health Ingredients

05 November 2024 | Tuesday | News

The acquisition enhances OmniActive's capabilities in sports, joint, men's health, and more, bringing innovative ingredients like Muvz, RedNite, and Oxyjun to global markets.
Picture Courtesy | Public Domain

Picture Courtesy | Public Domain

OmniActive Health Technologies (OmniActive) announced the acquisition of ENovate Biolife (ENovate), further strengthening its commitment to innovative, clinically proven health ingredients for consumer products.

Latha and Jayesh Chaudhary, both pharmacists by training, founded Exotic Natural in 1994, the year of DSHEA, aiming to develop botanicals and marine ingredients for health solutions. Building upon that success, ENovate, headquartered in Mumbai, India, was established in 2009, to focus on developing proprietary, clinically studied botanical ingredients, across sports and active nutrition, joint and lower back support, men's health, heart health and upcoming advances in muscle and digestive health.

"ENovate's approach to ingredients perfectly aligns with OmniActive's mission of delivering proven products that make a meaningful difference in consumers' lives," said Sanjay Mariwala, founder and managing director of OmniActive. "ENovate has done a remarkable job bringing multiple standout ingredients to the market including Muvz, RedNite, and the award-winning Oxyjun. We look forward to bringing these newly acquired ingredients to more brands and formulation partners looking to serve health-conscious consumers around the world."

"We are extremely proud of the strides we have made to help our loyal customers deliver products formulated with clinically backed ingredients to address consumer health and performance needs," said Jayesh Chaudhary, founder and CEO of ENovate. "OmniActive's comprehensive capabilities spanning across clinical research, R&D, regulatory, marketing and operations, along with global reach, position us well to elevate these ingredients even further."

In 2019, OmniActive initiated a partnership with ENovate through a U.S. licensing agreement for enXtra, a clinically studied mental energy ingredient. This collaboration proved successful, leading to a global expansion of the agreement. Since then, enXtra has been effectively commercialized by numerous premium brands worldwide.

To learn more about OmniActive and its ingredients visit: www.omniactives.com.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close